VAXX News

It was another busy week for the IPO market as 15 new issuers went public, with Rivian (RIVN) in the spotlight. The pre-revenue electric truck developer became the largest IPO of 2021, raising nearly $12 billion in the largest IPO since Alibaba (NYSE: BABA) in 2014, and popped 29% in its public debut. Rivian Automotive (RIVN) upsized and priced...read more

Vaxxinity, a Phase 2 biotech developing vaccine therapies for chronic diseases using synthetic peptides, raised $78 million by offering 6 million shares at $13, below the range of $14 to $16. The company offered 0.7 million fewer shares than anticipated. Vaxxinity's vision is to disrupt the existing treatment paradigm for chronic diseases, and believes its synthetic peptide...read more

The IPO market is expected to stay busy with 11 IPOs schedule to raise $10.2 billion in the week ahead.   Electric truck developer Rivian Automotive (RIVN) plans to raise $8.0 billion at a $57.1 billion market cap. This founder-led company is developing and manufacturing a portfolio of electric adventure-ready consumer and commercial SUVs, vans, and pickup...read more

Vaxxinity, a Phase 2 biotech developing vaccine therapies for chronic diseases using synthetic peptides, announced terms for its IPO on Friday. The Dallas, TX-based company plans to raise $101 million by offering 6.7 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Vaxxinity would command a fully diluted market value of $2.1 billion. ...read more